Skip to main content
Premium Trial:

Request an Annual Quote

Affymetrix, BioDiscovery to Co-market Data Analysis Tools for OncoScan Service


Affymetrix will market BioDiscovery's Nexus Copy Number data analysis tool to users of its OncoScan FFPE Express Service, the companies said this week.

Under the terms of the deal, customers accessing the OncoScan FFPE Express Service through Affymetrix Research Services Laboratory will receive a preliminary Nexus Copy Number data analysis.

Additionally, BioDiscovery will provide a "one-on-one consultation session" to assist researchers with the downstream analysis of their data to "elucidate pathways and identify copy number variations and copy-neutral loss of heterozygosity events."

BioDiscovery has customized its Nexus Copy Number software to provide analysis of OncoScan FFPE Express microarray data, the companies said, but did not elaborate.

Affy launched the second version of the service last month. OncoScan FFPE Express 2.0 enables users to analyze DNA from formalin-fixed, paraffin-embedded tissues to extract retrospective clinical data from archived samples (BAN 4/5/2011).

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.